EDWARDS LIFESCIENCES CORP (1EW.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1EW - US28176E1082 - Common Stock
73.47 EUR
+6.99 (+10.51%)
Taking everything into account, 1EW scores 7 out of 10 in our fundamental rating. 1EW was compared to 68 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making 1EW a very profitable company, without any liquidiy or solvency issues. 1EW is valied quite expensively at the moment, while it does show a decent growth rate. With these ratings, 1EW could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
1EW had positive earnings in the past year.
1EW had a positive operating cash flow in the past year.
Each year in the past 5 years 1EW has been profitable.
Each year in the past 5 years 1EW had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 10.31%, 1EW belongs to the best of the industry, outperforming 90.16% of the companies in the same industry.
1EW's Return On Equity of 13.40% is fine compared to the rest of the industry. 1EW outperforms 78.69% of its industry peers.
With an excellent Return On Invested Capital value of 12.50%, 1EW belongs to the best of the industry, outperforming 88.52% of the companies in the same industry.
1EW had an Average Return On Invested Capital over the past 3 years of 15.82%. This is significantly above the industry average of 9.73%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROIC | 12.5% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)15.82%
ROIC(5y)17.27%
1.3 Margins
Looking at the Profit Margin, with a value of 23.25%, 1EW belongs to the top of the industry, outperforming 93.44% of the companies in the same industry.
In the last couple of years the Profit Margin of 1EW has grown nicely.
Looking at the Operating Margin, with a value of 27.73%, 1EW belongs to the top of the industry, outperforming 98.36% of the companies in the same industry.
1EW's Operating Margin has been stable in the last couple of years.
1EW has a better Gross Margin (78.19%) than 91.80% of its industry peers.
1EW's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% |
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
2. Health
2.1 Basic Checks
1EW has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, 1EW has less shares outstanding
The number of shares outstanding for 1EW has been reduced compared to 5 years ago.
The debt/assets ratio for 1EW has been reduced compared to a year ago.
2.2 Solvency
1EW has an Altman-Z score of 12.38. This indicates that 1EW is financially healthy and has little risk of bankruptcy at the moment.
1EW has a Altman-Z score of 12.38. This is amongst the best in the industry. 1EW outperforms 95.08% of its industry peers.
1EW has a debt to FCF ratio of 0.75. This is a very positive value and a sign of high solvency as it would only need 0.75 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.75, 1EW belongs to the best of the industry, outperforming 93.44% of the companies in the same industry.
1EW has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
1EW's Debt to Equity ratio of 0.06 is amongst the best of the industry. 1EW outperforms 86.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Altman-Z | 12.38 |
ROIC/WACC1.45
WACC8.62%
2.3 Liquidity
A Current Ratio of 4.00 indicates that 1EW has no problem at all paying its short term obligations.
1EW has a Current ratio of 4.00. This is amongst the best in the industry. 1EW outperforms 91.80% of its industry peers.
A Quick Ratio of 3.29 indicates that 1EW has no problem at all paying its short term obligations.
1EW's Quick ratio of 3.29 is amongst the best of the industry. 1EW outperforms 91.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 |
3. Growth
3.1 Past
The earnings per share for 1EW have decreased by -3.75% in the last year.
1EW shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.13% yearly.
Looking at the last year, 1EW shows a small growth in Revenue. The Revenue has grown by 4.67% in the last year.
1EW shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.58% yearly.
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
3.2 Future
Based on estimates for the next years, 1EW will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.50% on average per year.
The Revenue is expected to grow by 8.55% on average over the next years. This is quite good.
EPS Next Y0.42%
EPS Next 2Y5.67%
EPS Next 3Y7.57%
EPS Next 5Y9.5%
Revenue Next Year4.33%
Revenue Next 2Y7.03%
Revenue Next 3Y7.98%
Revenue Next 5Y8.55%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 32.95, the valuation of 1EW can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as 1EW.
1EW is valuated rather expensively when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 28.93, 1EW can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as 1EW.
1EW's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.95 | ||
| Fwd PE | 28.93 |
4.2 Price Multiples
1EW's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 1EW is more expensive than 60.66% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as 1EW.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 61.42 | ||
| EV/EBITDA | 25.01 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1EW does not grow enough to justify the current Price/Earnings ratio.
1EW has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)77.74
PEG (5Y)4.62
EPS Next 2Y5.67%
EPS Next 3Y7.57%
5. Dividend
5.1 Amount
1EW does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1EW (11/11/2025, 7:00:00 PM)
73.47
+6.99 (+10.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.08%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap42.63B
Revenue(TTM)5.88B
Net Income(TTM)1.37B
Analysts77.67
Price Target81.34 (10.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-4.64%
Revenue beat(12)2
Avg Revenue beat(12)-3.41%
Revenue beat(16)2
Avg Revenue beat(16)-3.45%
PT rev (1m)5.02%
PT rev (3m)5.02%
EPS NQ rev (1m)-1.51%
EPS NQ rev (3m)-1.51%
EPS NY rev (1m)4.19%
EPS NY rev (3m)4.19%
Revenue NQ rev (1m)2.72%
Revenue NQ rev (3m)2.72%
Revenue NY rev (1m)3.45%
Revenue NY rev (3m)3.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.95 | ||
| Fwd PE | 28.93 | ||
| P/S | 8.35 | ||
| P/FCF | 61.42 | ||
| P/OCF | 48.3 | ||
| P/B | 4.81 | ||
| P/tB | 6.72 | ||
| EV/EBITDA | 25.01 |
EPS(TTM)2.23
EY3.04%
EPS(NY)2.54
Fwd EY3.46%
FCF(TTM)1.2
FCFY1.63%
OCF(TTM)1.52
OCFY2.07%
SpS8.8
BVpS15.27
TBVpS10.93
PEG (NY)77.74
PEG (5Y)4.62
Graham Number27.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROCE | 13.97% | ||
| ROIC | 12.5% | ||
| ROICexc | 18.63% | ||
| ROICexgc | 29.56% | ||
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% | ||
| FCFM | 13.59% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)15.82%
ROIC(5y)17.27%
ROICexc(3y)20.51%
ROICexc(5y)22.13%
ROICexgc(3y)29.09%
ROICexgc(5y)31.03%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score6
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 138.79% | ||
| Cap/Sales | 3.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.86% | ||
| Profit Quality | 58.45% | ||
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 | ||
| Altman-Z | 12.38 |
F-Score6
WACC8.62%
ROIC/WACC1.45
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
EPS Next Y0.42%
EPS Next 2Y5.67%
EPS Next 3Y7.57%
EPS Next 5Y9.5%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
Revenue Next Year4.33%
Revenue Next 2Y7.03%
Revenue Next 3Y7.98%
Revenue Next 5Y8.55%
EBIT growth 1Y4.68%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year10.47%
EBIT Next 3Y11.73%
EBIT Next 5Y12.76%
FCF growth 1Y1.45%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-2.42%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%
EDWARDS LIFESCIENCES CORP / 1EW.MI FAQ
Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a fundamental rating of 7 / 10 to 1EW.MI.
What is the valuation status of EDWARDS LIFESCIENCES CORP (1EW.MI) stock?
ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (1EW.MI). This can be considered as Overvalued.
How profitable is EDWARDS LIFESCIENCES CORP (1EW.MI) stock?
EDWARDS LIFESCIENCES CORP (1EW.MI) has a profitability rating of 8 / 10.
What is the valuation of EDWARDS LIFESCIENCES CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (1EW.MI) is 32.95 and the Price/Book (PB) ratio is 4.81.
What is the expected EPS growth for EDWARDS LIFESCIENCES CORP (1EW.MI) stock?
The Earnings per Share (EPS) of EDWARDS LIFESCIENCES CORP (1EW.MI) is expected to grow by 0.42% in the next year.